Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy
- PMID: 12944420
- DOI: 10.1093/hmg/ddg293
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset autosomal dominant muscular dystrophy that results from small expansions of a polyalanine tract in the PABPN1 gene. Intranuclear inclusions are the pathological hallmark of OPMD. The mechanism by which protein aggregation in OPMD might relate to a toxic gain-of-function has so far remained elusive. Whether protein aggregates themselves are pathogenic or are the consequence of an unidentified underlying molecular mechanism is still unclear. Here, we report that protein aggregation in a cell model of OPMD directly impaires the function of the ubiquitin-proteasome pathway (UPP) as well as molecular chaperone functions. The proteasome inhibitor lactacystin causes significant increase of protein aggregation and toxicity. Moreover, overexpression of molecular chaperones (HSP40 and HSP70) suppressed protein aggregation and toxicity. We also provide evidence that mPABPN1-ala17 protein aggregation proportionally correlates with toxicity. Furthermore, we show that co-expression of chaperones in our OPMD cell model increases the solubility of mPABPN1-ala17 and transfected cell survival rate. Our studies suggest that molecular regulators of polyalanine protein solubility and degradation may provide insights into new mechanisms in OPMD pathogenesis. Further analysis of the cellular and molecular mechanisms by which UPP and molecular chaperones influence the degradation of misfolded proteins could provide novel concepts and targets for the treatment and understanding of the pathogenesis of OPMD and neurodegenerative diseases.
Similar articles
-
Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.Hum Mol Genet. 2005 Dec 1;14(23):3673-84. doi: 10.1093/hmg/ddi395. Epub 2005 Oct 20. Hum Mol Genet. 2005. PMID: 16239242
-
Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.Traffic. 2005 Sep;6(9):766-79. doi: 10.1111/j.1600-0854.2005.00315.x. Traffic. 2005. PMID: 16101680
-
Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.Hum Mol Genet. 2004 Apr 15;13(8):829-38. doi: 10.1093/hmg/ddh101. Epub 2004 Feb 19. Hum Mol Genet. 2004. PMID: 14976164
-
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4(Suppl 4):16412-8. doi: 10.1073/pnas.182426899. Epub 2002 Aug 20. Proc Natl Acad Sci U S A. 2002. PMID: 12189209 Free PMC article. Review.
-
Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.
Cited by
-
PABPN1: molecular function and muscle disease.FEBS J. 2013 Sep;280(17):4230-50. doi: 10.1111/febs.12294. Epub 2013 May 24. FEBS J. 2013. PMID: 23601051 Free PMC article. Review.
-
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.Nucleic Acids Res. 2016 Dec 15;44(22):10929-10945. doi: 10.1093/nar/gkw703. Epub 2016 Aug 9. Nucleic Acids Res. 2016. PMID: 27507886 Free PMC article.
-
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.Hum Mol Genet. 2019 Oct 1;28(19):3301-3308. doi: 10.1093/hmg/ddz167. Hum Mol Genet. 2019. PMID: 31294444 Free PMC article.
-
Expanded polyalanine tracts function as nuclear export signals and promote protein mislocalization via eEF1A1 factor.J Biol Chem. 2017 Apr 7;292(14):5784-5800. doi: 10.1074/jbc.M116.763599. Epub 2017 Feb 28. J Biol Chem. 2017. PMID: 28246169 Free PMC article.
-
The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response.Open Biol. 2023 Apr;13(4):230008. doi: 10.1098/rsob.230008. Epub 2023 Apr 12. Open Biol. 2023. PMID: 37042114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
